GrafTech Announces First Quarter 2024 Earnings Conference Call and Webcast
Get Alerts EAF Hot Sheet
Join SI Premium – FREE
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) (the “Company”) will hold its First Quarter 2024 Earnings Conference Call and Webcast on Friday, April 26, 2024 at 10:00 a.m. (EDT). The call will be hosted by senior management to discuss financial results for the first quarter ended March 31, 2024 and current business initiatives. These financial results will be released on Friday, April 26, 2024 before market open and will be available on our investor relations website at: http://ir.graftech.com.
The conference call dial-in number is +1 (800) 717-1738 toll-free in North America or +1 (289) 514-5100 for overseas calls, conference ID: 46406. Live audio of the conference call will be available via webcast on our website or can be accessed at: https://bit.ly/43I9m9e. Archived replays of the conference call and webcast will be made available on our investor relations website at: http://ir.graftech.com.
About GrafTech
GrafTech International Ltd. is a leading manufacturer of high-quality graphite electrode products essential to the production of electric arc furnace steel and other ferrous and non-ferrous metals. The Company has a competitive portfolio of low-cost, ultra-high power graphite electrode manufacturing facilities, with some of the highest capacity facilities in the world. We are the only large-scale graphite electrode producer that is substantially vertically integrated into petroleum needle coke, our key raw material for graphite electrode manufacturing. This unique position provides us with competitive advantages in product quality and cost.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240402092498/en/
Michael Dillon
216-676-2000
Source: GrafTech International Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades On Holding AG (ONON) to Market Perform
- ESS Tech, Inc. Announces Second Quarter 2026 Financial Results
- Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share